Securities Purchase Agreements [Member]
Type of Arrangement and Non-arrangement Transactions [Axis]
Private Placement [Member]
Sale of Stock [Axis]
Accredited Investors And Institutions [Member]
Legal Entity [Axis]
10% Convertible Promissory Note (2014 Unit Notes) [Member]
Debt Instrument [Axis]
2014 Unit Restricted Stock [Member]
Equity Components [Axis]
2014 Unit Warrants [Member]
Accredited Investors [Member]
Promissory Notes And Payables [Member]
Series B Preferred Stock [Member]
Platinum Long Term Growth VII, LLC [Member]
Warrant [Member]
Subsequent Event [Member]
Subsequent Event Type [Axis]
Common Stock [Member]
Senior Secured Exchange Note [Member]
Senior Secured Investment Note [Member]
Senior Secured Investment Note [Member]
Senior Secured Investment Note [Member]
Senior Secured Investment Note [Member]
Senior Secured Exchange Note & Investment Note [Member]
10% Convertible Promissory Notes Maturing On July 30, 2014 [Member]
Senior Secured Notes [Member]
7.5% Notes Payable (Service providers for accounts payable converted to notes payable) [Member]
5.75% & 10.25% Notes payable (Insurance premium financing company) [Member]
10% Notes Payable (Vendors for accounts payable converted to notes payable) [Member]
7.0% Note payable (August 2012) [Member]
Total Notes Payable To Unrelated Parties [Member]
October 2012 7.5% Note Payable [Member]
October 2012 7.5% Note Payable [Member]
7.5% A Notes Payable August 2012 (Service providers for accounts payable converted to notes payable) [Member]
7.5% B Notes Payable August 2012 (Service providers for accounts payable converted to notes payable) [Member]
Burr Pilger & Mayer [Member]
Desjardins Securities [Member]
McCarthy Tetrault [Member]
Morrison & Foerster [Member]
University Health Network [Member]
10% Promissory Note [Member]
Icahn School of Medicine at Mount Sinai [Member]
Restricted Common Stock [Member]
Acquired Unit Notes [Member]
Investor Unit Notes [Member]
Platinum Unit Notes And Acquired Unit Notes [Member]
Cato Notes [Member]
Cato Holding Co & Cato Research Ltd [Member]
Related Party [Axis]
Cato Holding Co. [Member]
Cato Research Ltd. [Member]
Pre-Modification [Member]
Scenario [Axis]
Post-Modification [Member]
Maximum [Member]
Range [Axis]
Minimum [Member]
National Jewish Health [Member]
MicroConstants, Inc [Member]
Two Professional Service Providers & Former Employee [Member]
Platinum Warrants Agreement [Member]
Series A Preferred Stock [Member]
Antidilutive Securities [Axis]
Series C Preferred Stock [Member]
2008 And 1999 Stock Incentive Plans [Member]
Warrant [Member]
Platinum Warrant [Member]
Note Exchange and Purchase Agreement [Member]
10% Senior Secured Convertible Notes [Member]
Office Furniture And Equipment [Member]
Property, Plant and Equipment, Type [Axis]
Cato Holding Co [Member]
2008 Stock Incentive Plan [Member]
Plan Name [Axis]
1999 Stock Incentive Plan [Member]
Non-Officer Employees And Certain Strategic Consultants [Member]
Two Parties [Member]
Investor Relations Agreement [Member]
New Independent [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Note Receivable from Sale of Stock [Member]
Accumulated Deficit [Member]
Recurring [Member]
Measurement Frequency [Axis]
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Hierarchy [Axis]
Significant Other Observable Inputs (Level 2) [Member]
Significant Unobservable (Level 3) [Member]
Laboratory Equipment [Member]
Tenant Improvements [Member]
Computers and Network Equipment [Member]
Series B Warrants [Member]
2013 Unit Warrants [Member]
Warrants Subject To Exercise Price [Member]
Warrant One [Member]
Warrant Two [Member]
Warrant Three [Member]
Warrant Four [Member]
Warrant Five [Member]
Warrant Six [Member]
2008 and 1999 Stock Incentive Plans [Member]
Unsecured Promissory Note (2012 CHC Note) [Member]
7.5% Unsecured Promissory Note [Member]
Unregistered Common Stock [Member]
VistaGen California's [Member]
Mr. Shawn Singh [Member]
4.90% Unsecured Promissory Note [Member]
Promissory Note [Member]
U.S.National Institutes Of Health With Preclinical Development Agreement [Member]
AV-101 [Member]
Products and Services [Axis]
Research and Development Expense [Member]
Income Statement Location [Axis]
General and Administrative Expense [Member]
Exercise Price $8.00 [Member]
Exercise Price Range [Axis]
Exercise Price $9.25 [Member]
Exercise Price $10.00 [Member]
Exercise Price From $14.40 To $36.00 [Member]
Certificate Of Designation [Member]
Accredited Investors And Institutions (Including Platinum) [Member]
Securities Purchase Agreements [Member]
Senior Secured 10% Convertible Promissory Notes
10% Convertible Notes [Member]
Registration Statement [Member]
Registration Payment Arrangement by Arrangement [Axis]
Series B Preferred Unit Offering [Member]
Exchange Agreement [Member]
Platinum and Montsant Partners, LLC [Member]
Warrant [Member]
Note Exchange & Purchase Agreement [Member]
Series A Exchange Warrant [Member]
Other Holder [Member]
Warrant Exchange Agreements [Member]
Note And Warrant Amendment Agreements [Member]
Legal Services Related To Debt Restructuring [Member]
Restructuring Type [Axis]
Financial Advisory And Corporate Development Service [Member]
Two Independent Contractors [Member]
Corporate Development Service [Member]
Intellectual Property-Related Legal Services [Member]
Legal Services [Member]
Investor Relations [Member]
Investment Banking Agreements [Member]
Four Parties [Member]
Eleven Professional Service Providers [Member]
Consulting Agreement [Member]
Consultant [Member]
Consultant One [Member]
Legal Counsel [Member]
Officers And Independent Members Of The Board [Member]
Notes Receivable [Member]
Receivable Type [Axis]
Other Expenses [Member]
Stock Option [Member]
Award Type [Axis]
Warrant (Officers & Directors) [Member]
Vested Warrant (Officers, Directors & Consultants) [Member]
Vested Warrant (Officers, Directors & Consultants) [Member]
Registered Common Stock [Member]
Stock Conversion Description [Axis]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Trading Symbol
Document Period End Date
Amendment Flag
Current Fiscal Year End Date
Entity a Well-known Seasoned Issuer
Entity a Voluntary Filer
Entity's Reporting Status Current
Entity Filer Category
Entity Public Float
Entity Common Stock, Shares Outstanding
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement [Table]
Statement [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Security deposits and other assets
Total assets
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable
Accrued expenses
Current portion of senior secured convertible promissory notes and accrued interest
Current portion of notes payable, net of discount of $0 at March 31, 2016 and $474,500 at March 31, 2015, and accrued interest
Current portion of notes payable to related parties, net of discount of $0 at March 31, 2016 and $54,500 at March 31, 2015, and accrued interest
Convertible promissory notes and accrued interest, net of discount of $0 at March 31, 2016 and $180,000 at March 31, 2015, respectively
Capital lease obligations
Total current liabilities
Non-current liabilities:
Senior secured convertible promissory notes and accrued interest
Notes payable
Warrant liability
Accrued dividends on Series B Preferred Stock
Deferred rent liability
Capital lease obligations
Total non-current liabilities
Total liabilities
Commitments and contingencies
Stockholders' deficit:
Preferred stock
Common stock, $0.001 par value; 30,000,000 shares and 10,000,000 shares authorized at March 31, 2016 and 2015, respectively; 2,623,145 and 1,677,110 shares issued at March 31, 2016 and 2015, respectively
Additional paid-in capital
Treasury stock, at cost, 135,665 shares of common stock held at March 31, 2016 and 2015
Accumulated deficit
Total stockholders' deficit
Total liabilities and stockholders' deficit
Current portion of notes payable, discount
Current portion of notes payable to related parties, discount
Convertible promissory notes and accrued interest, discount
Preferred stock, par value (in dollars per share)
Preferred stock, authorized
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value (in dollars per share)
Common stock, authorized
Common stock, issued
Treasury stock, shares
Income Statement [Abstract]
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other expenses, net:
Interest expense, net
Change in warrant liability
Loss on extinguishment of debt
Other expense
Loss before income taxes
Income taxes
Net loss and comprehensive loss
Accrued dividends on Series B Preferred stock
Deemed dividend on Series B Preferred Units
Net loss attributable to common stockholders
Basic net loss attributable to common stockholders per common share (in dollars per share)
Diluted net loss attributable to common stockholders per common share (in dollars per share)
Weighted average shares used in computing:
Basic net loss attributable to common stockholders per common share (in shares)
Diluted net loss attributable to common stockholders per common share (in shares)
Consolidated Statements Of Cash Flows
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of discounts on convertible and promissory notes
Change in warrant liability
Stock-based compensation
Expense related to modification of warrants, including exchange of warrants for Series C Preferred and common stock
Amortization of deferred rent
Fair value of common stock granted for services
Fair value of Series B Preferred stock granted for services
Fair value of warrants granted for services and interest
Gain on currency fluctuation
Loss on extinguishment of debt
Loss on disposition of equipment
Reversal of interest income on note receivable for stock purchase
Loss on settlement of note receivable for common stock purchase
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable and accrued expenses, including accrued interest
Net cash used in operating activities
Cash flows from investing activities:
Purchases of equipment
Cash flows from financing activities:
Net proceeds from issuance of common stock Units
Net proceeds from issuance of Series B Preferred Units
Repayment of capital lease obligations
Repayment of notes
Net cash provided by financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow activities:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of noncash activities:
Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred
Insurance premiums settled by issuing note payable
Accounts payable settled by issuance of common stock or notes payable and common stock
Balances at beginning
Balances at beginning (in shares)
Allocated proceeds from sale of common stock Units for cash under 2014 Unit Private Placement, including beneficial conversion feature
Allocated proceeds from sale of common stock Units for cash under 2014 Unit Private Placement, including beneficial conversion feature (in shares)
Proceeds from sale of Series B Preferred Units for cash under 2015 Series B Preferred Unit Private Placement
Proceeds from sale of Series B Preferred Units for cash under 2015 Series B Preferred Unit Private Placement (in shares)
Share-based compensation expense
Conversion of Senior Secured and subordinate promissory notes into Series B Preferred stock, including recapture of beneficial conversion feature upon conversion
Conversion of Senior Secured and subordinate promissory notes into Series B Preferred stock, including recapture of beneficial conversion feature upon conversion (in shares)
Elimination of warrant liability resulting from modification of PLTG Warrants
Exchange of common stock for Series B Preferred stock
Exchange of common stock for Series B Preferred stock (in shares)
Accrued dividends on Series B Preferred stock
Conversion of Series B Preferred stock into common stock, including common stock issued in payment of accrued dividends
Conversion of Series B Preferred stock into common stock, including common stock issued in payment of accrued dividends (in shares)
Exchange of common stock for Series C Preferred stock
Exchange of common stock for Series C Preferred stock (in shares)
Exchange of outstanding warrants for Series C Preferred stock
Exchange of outstanding warrants for Series C Preferred stock (in shares)
Exchange of outstanding warrants for common stock and other warrant modifications
Exchange of outstanding warrants for common stock and other warrant modifications (in shares)
Fair value of common stock, Series B Preferred stock and warrants granted for services
Fair value of common stock, Series B Preferred stock and warrants granted for services (in shares)
Payment on and settlement of note receivable from sale of stock
Incremental fair value of modified warrants
Fair Value of common stock issued for services
Fair Value of common stock issued for services (in shares)
Fair value of common stock and warrants issued in settlement oftechnology license expenses
Fair value of common stock and warrants issued in settlement oftechnology license expenses (in shares)
Fair value of warrants issued to Morrison & Foerster, Cato Research Ltd. and University Health Network in connection with accruedinterest on underlying notes
Effect of amendments of 2013 Unit Notes and warrants, including repurchase of beneficial conversion feature
Effect of amendments of PLTG Senior Secured Promissory Notes, including repurchase of beneficial conversion feature
Balances at end
Balances at end (in shares)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business
Accounting Policies [Abstract]
Basis of Presentation
Summary of Significant Accounting Policies
Fair Value Disclosures [Abstract]
Fair Value Measurements
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets
Property, Plant and Equipment [Abstract]
Property and Equipment
Payables and Accruals [Abstract]
Accrued Expenses
Debt Disclosure [Abstract]
Convertible Promissory Notes and Other Notes Payable
Stockholders' Equity Note [Abstract]
Capital Stock
Research and Development [Abstract]
Research and Development Expenses
Income Tax Disclosure [Abstract]
Income Taxes
Licensing and Collaborative Agreements
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Option Plans and 401(k) Plan
Related Party Transactions [Abstract]
Related Party Transactions
Commitments and Contingencies Disclosure [Abstract]
Commitments, Contingencies, Guarantees and Indemnifications
Subsequent Events [Abstract]
Subsequent Events
Quarterly Financial Information Disclosure [Abstract]
Supplemental Financial Information
Use of Estimates
Principles of Consolidation
Cash and Cash Equivalents
Property and Equipment
Impairment or Disposal of Long-Lived Assets
Revenue Recognition
Research and Development Expenses
Stock-Based Compensation
Income Taxes
Concentrations of Credit Risk
Warrant Liability
Comprehensive Loss
Loss per Common Share
Recent Accounting Pronouncements
Schedule of basic and diluted net loss attributable to common stockholders per share
Schedule of potentially dilutive securities excluded in determining diluted net loss per common share
Schedule of fair value hierarchy for liabilities measured at fair value on a recurring basis
Schedule of changes in Level 3 liabilities measured at fair value on a recurring basis
Schedule of prepaid expenses and other current assets
Schedule of property and equipment
Schedule of accrued expenses
Schedule of the components of the Company's convertible promissory notes and other notes payable
Schedule of Black Scholes option pricing model
Schedule of the aggregate allocation unit sales proceeds based on the relative fair values
Schedule of Black Scholes option pricing model
Schedule of outstanding warrants to purchase shares
Schedule of reserved shares of common stock for future issuance
Schedule of effective income tax rate
Schedule of components of the deferred tax assets
Schedule of share-based compensation expense
Schedule of Black Scholes option valuation model
Schedule of stock option plans
Schedule of stock options outstanding and exercisable
Schedule of capital lease obligations
Schedule of amortization expense for assets recorded under capital leases
Schedule of future minimum payments under operating leases
Schedule of future minimum principal payments related to long-term debt
Schedule of quarterly financial information
Description of reverse stock split ratio
Cash proceeds from issuance and sale of notes
Cash proceeds from government research grant awards, strategic collaboration payments and other revenues
Cash proceeds from issuance of equity securities
Aggregate face amount
Debt instrument maturity date range start
Debt instrument maturity date range end
Description of conversion terms
Number of shares issued
Warrant exercisable date
Warrant exercise price (in dollars per share)
Extinguishment of debt, amount
Number of shares issued upon debt conversion
Description of lender names
Warrant term
Expected cash expenditures
Share price (in dollars per share)
Numerator:
Net loss attributable to common stockholders for basic earnings per share
less: change in fair value of warrant liability attributable to outstanding warrants issued to PLTG
Net loss for diluted earnings per share attributable to common stockholders
Denominator:
Weighted average basic common shares outstanding (in shares)
Assumed conversion of dilutive securities:
Warrants to purchase common stock
Potentially dilutive common shares assumed converted
Denominator for diluted earnings per share - adjusted weighted average shares
Basic net loss attributable to common stockholders per common share
Diluted net loss attributable to common stockholders per common share
Total
Estimated useful lives
Exercise price (in dollars per share)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning
Mark to market loss included in net loss
Elimination of liability upon modification of warrants
Balance at end
Insurance
Prepaid compensation under financial advisory and other consulting agreements
Public offering expenses
Legal fees
Technology license fees and all other
Prepaid expenses and other current assets
Property and equipment, gross
Accumulated depreciation and amortization
Accrued professional services
Accrued AV-101 development expenses
Accrued compensation
All other
Accrued expenses
Principal Balance
Accrued Inrerest
Total
Issuance Date
Maturity Date
Principal Balance :
Aggregate note discount
Net Senior notes
less: current portion
Senior notes - non-current portion and discount
Accrued Interest :
Aggregate note discount
Net Senior notes
less: current portion
Senior notes - non-current portion and discount
Total
Aggregate note discount
Net Senior notes
less: current portion
Senior notes - non-current portion and discount
Market Price (in dollars per share)
Exercise price per share
Risk-free interest rate
Contractual term in years
Volatility
Dividend rate
Warrant shares
Weighted Average Fair Value per share
Assumption:
Debt conversion price (in dollars per share)
Amortized discounts
Percentage of excess effective interest rates
Stem cell technology license maintenance fees and reimbursable patent prosecution costs
Additional Stem cell technology license maintenance fees and reimbursable patent prosecution costs
Repayment of debt
Dividend rate
Non- cash loss on extinguishment of debt
Debt conversion amount
Maturity date
Debt conversion premium
Debt fair value
Warrant fair value
Aggregate fair value
Unamortized discounts
Past due accounts payable
Number of warrnts issued upon conversion
Description of warrant exercise price
Increased aggregate fair value
Description of warrant maturity date
Description of agreement terms
Warrant Shares Issued
Term (Years)
Risk free Interest Rate
Dividend Rate
Per Share Fair Value of Warrant
Aggregate Fair Value of Unit Warrants
Aggregate Proceeds of Unit Sales
Aggregate Allocation of Proceeds Based on Relative Fair Value of:
Exercise Price (in dollars per share)
Expense recognized
Exercise Price per Share
Expiration Date
Shares Subject to Purchase
Upon exchange of all shares currently issued and outstanding
Reserved for future issuance
Subject to outstanding awards
Available for future grants
Common stock par value (in dollars per share)
Preferred stock authorized
Preferred stock par value (in dollars per share)
Description of conversion
Description of preferred stock voting rights
Number of preferred stock outstanding
Number of common shares converted
Initial up-front cash payment
Aggregate gross proceeds
Description of stock trading
Percent of preferred stock accrued dividends
Accrued dividends
Net loss on accrued dividends
Preferred stock liquidation value
Proceeds from private placement
Face amount
Conversion price (in dollars per share)
Number of shares converted
Principal and accrued but unpaid interest
Number of shares purchased
Number of shares converted
Additional number of shares issued
Number of common shares purchased
Number of common shares exchanged
Fair value of stock issued
Value of additional shares issued
Loss on debt extinguishment
Number of shares issued accrued dividend
Aggregate amount of deemed dividend
Number of common shares registered
Accrued dividends
Number of shares exchanged
Number of shares canceled
Value of shares canceled
Number of common shares purchased
Weighted average fair value (in dollars per share)
Fair value of warrant
Market price per share (in dollars per share)
Exercise price per share (in dollars per share)
Expected dividend rate
Fair value of warrant modification expense
Increase in fair value
Value of shares issued
Fair value of stock
Remaining contractual term
Number of shares issued for services
Value of shares issued for services
Prepaid expense
Number of contracts
Cash paid
General and administrative expense
Research and development expense
Additional Compensation
Reduction in exercise price (in dollars per share)
Number of unregistered common shares purchased
Additional number of shares purchased
Payment received for stock sold to investor
Cash payment received
Outstanding principal balance
Loss on settlement of note
Computed expected tax benefit
Tax effect of loss on debt extinguishment
Tax effect of warrant modifications
Tax effect of Warrant Liability mark to market
Other losses not benefitted
Other
Income tax expense
Deferred tax assets:
Net operating loss carryovers
Basis differences in fixed assets
Accruals and reserves
Total deferred tax assets
Valuation allowance
Net deferred tax assets
Valuation allowance increase
U.S. federal net operating loss carryforwards
State net operating loss carryforwards
Grant receivable
Subsequently increased grant receivable
Research and development expenses
Total stock-based compensation expense
Exercise price
Market price on date of grant
Risk-free interest rate
Expected term (years)
Volatility
Expected dividend yield
Fair value per share at grant date
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding at beginning
Options granted
Options exercised
Options forfeited
Options expired
Options outstanding at end
Options exercisable at end
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Options outstanding at beginning
Options granted
Options exercised
Options forfeited
Options expired
Options outstanding at end
Options exercisable at end
Weighted average grant-date fair value of options granted
Number Outstanding
Weighted Average Remaining Years until Expiration
Weighted Average Exercise Price
Number Exercisable
Exercisable Weighted Average Exercise Price
Maximum number of shares granted
Shares issued for future issuance
Term of award
Number of granted shares
Number of share available for grant
Aggregate intrinsic value outstanding
Value of exercisable options
Unrecognized compensation cost
Expected date of recognition
Vesting date
Total interest expense
Aggregate face amount cancelled
Repayments of debt
Related party transation amount
Office equipment
Accumulated depreciation
Net book value
Fiscal Years Ending March 31,
2017
2018
Future minimum lease payments
Less imputed interest included in minimum lease payments
Present value of minimum lease payments
Less current portion
Non-current capital lease obligation
Fiscal Years Ending March 31,
2017
2018
Total
Fiscal Years Ending March 31,
2017
2018
2019
Thereafter through June 2019
Total
Facility rent expense
Number of share converted
Number of shares issued upon conversion
Additional number of shares issued upon conversion
Accrued dividend
Dividend (in dollars per share)
Public sales price (in dollars per share)
Gross cash proceeds from issuance of equity securities
Net cash proceeds from issuance of equity securities
Total operating expenses
Loss from operations
Other expense
Loss before income taxes
Net loss attributable to common stockholders
Basic and diluted net loss per common share (in dollars per share)
Basic net loss per common share (in dollars per share)
Diluted net loss per common share (in dollars per share)
Basic and diluted net loss per common share (in shares)
Basic net loss per common share (in shares)
Diluted net loss per common share (in shares)
Period of time between issuance and maturity of warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Information about securities purchase agreements.
It refers to an legal entity.
Stock units, which are a type of ownership interest in a corporation.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
It refers to an legal entity.
A written promise to pay a note to a third party.
It refers to an legal entity.
Refers to expected cash expenditure calculated during the period.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
It refers to an legal entity.
It refers to an legal entity.
It refers to an legal entity.
It refers to an legal entity.
It refers to an legal entity.
Refers to percentage of excess interest rate over the effective interest rate during the period.
Refers to additional costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark.
Refers to premium earned while debt instrument conversion during the period.
A written promise to pay a note to a third party.
It refers to an legal entity.
Restricted stock that is subordinate to all other stock of the issuer.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
Fair value price of a single share of a number of saleable stocks of a company.
A written promise to pay a note to a third party.
Description of exercise price per share or per unit of warrants or rights outstanding.
The value of the financial instrument(s) that the increased original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
A written promise to pay a note to a third party.
It refers to an legal entity.
It refers to an legal entity.
It refers to an legal entity.
Represents the amount as post reported after the correction of an error or other adjustment.
Description of maturity date of warrant.
Description of agreement terms.
It refers to an legal entity.
It refers to an legal entity.
It refers to an related party entity.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Gross amount of interest payable on debt, including, but not limited to, trade payables.
Refers to gross amount of debt instrument unamortized discount.
Refers to net amount of principal balance of debt instrument.
Refers to current portion of net amount of principal balance of debt instrument.
Refers to noncurrent portion of net amount of principal balance of debt instrument.
Refers to gross amount of debt instrument accrued interest unamortized discount.
Non-current amount of interest payable on debt, including, but not limited to, trade payables.
Information by plan name pertaining to equity-based compensation arrangements.
Information by plan name pertaining to equity-based compensation arrangements.
It refers to an related party entity.
It refers to an related party entity.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
It refers to an legal entity.
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'MM-YYYY' format.
Carrying value of security deposits and other assets as on balance sheet date.
Refers to amount in increase decrease of warrant liability during the period.
Refers to amount of accrued dividend on preferred stock during the period.
Refers to amount of deemed dividend on preferred stock during the period.
Refer to amount of expense related to modification of warrant exchange during the period.
Refers to amount of fair value of common stock granted for services.
Refers to amount of fair value of preferred stock granted for services.
Refers to amount of loss settlement on notes receivable.
Refers to amount of non cash expense insurance premium settled issuing notes payable during the period.
Refers to non cash amount of accounts payable settled by issuance of common stock or notes payable and common stock during the period.
Refers the value of shares issued under the 2014 unit private placement.
Refers the number of shares issued under the 2014 unit private placement.
Refers the value of shares issued for series B preferred stock under the 2015 unit private placement.
Refers the number of shares issued for series B preferred stock under the 2015 unit private placement.
Refers the value of shares issued for conversion of senior secured and subordinate promissory note into series B preferred stock.
Refers the number of shares issued for conversion of senior secured and subordinate promissory note into series B preferred stock.
Refers to adjustment for aditional paid in capital for elimination of warrant liability resulting from modification of platinum warrants.
Refers the value of shares issued for exchange of common stock for series B preferred stock.
Refers the number of shares issued for exchange of common stock for series B preferred stock.
Refers to accrued dividend on series B preferred stock.
Refers the value of shares issued for conversion of series B preferred stock into common stock including common stock issued in payment of accrued dividend.
Refers the number of shares issued for conversion of series B preferred stock into common stock including common stock issued in payment of accrued dividend.
Refers the value of shares issued for exchange of common stock for series C preferred stock.
Refers the number of shares issued for exchange of common stock for series C preferred stock.
Refers the value of shares issued for exchange of outstanding warrants for series C preferred stock.
Refers the number of shares issued for exchange of outstanding warrants for series C preferred stock.
Refers the value of shares issued for exchange of outstanding warrants for common stock and other warrant modification.
Refers the number of shares issued for exchange of outstanding warrants for common stock and other warrant modification.
Refers the value of shares issued for fair value of common stock for series B preferred stock grated for services.
Refers the number of shares issued for fair value of common stock for series B preferred stock grated for services.
Refers to amount of payments on notes receivable for sale of stock.
Refers the value of shares issued for fair value of common stock and warrant issued in settlement of technology license expenses..
Refers the number of shares issued for fair value of common stock and warrant issued in settlement of technology license expenses..
Refers to amount of additional adjustment paid in capital for warrants issued to Morrison & Foerster, Cato Research Ltd. and University Health Network in connection with accrued interest on underlying notes.
Refers to amount of additional adjustment paid in capital for effect of amendments of 2013 Unit Notes and warrants, including repurchase of beneficial conversion feature.
Refers to amount of additional adjustment paid in capital for effect of amendments of Platinum Senior Secured Promissory Notes, including repurchase of beneficial conversion feature.
Disclosure regarding of prepaid and other assets.
Disclosure policy regarding of warrant liability.
Amount of asset related to consideration paid in advance for compensation as on balance sheet date.
Amount of asset related to consideration paid in advance for public offering expenses as on balance sheet date.
Amount of asset related to consideration paid in advance for legal fees as on balance sheet date.
Information about property i.e. tenant improvements.
Carrying value as of the balance sheet date of obligations incurred through that date and payable for development expenses.
Carrying value as of the balance sheet date of obligations incurred through that date and payable for compensation.
The cash inflow from the proceeds based on relative fair value.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Information by plan name pertaining to equity-based compensation arrangements.
Refers to numbers of shares currently issued and outstanding for exchange.
Refers to number of outstanding awards.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
Unregistered stock that is subordinate to all other stock of the issuer.
It refers to an legal entity.
A written promise to pay a note to a third party.
A written promise to pay a note to a third party.
Refers to cancelled amount of debt instrument.
Refers to effective income tax rate reconciliation of warrant liability under mark to market.
Refers to effective income tax rate reconciliation for warrant modifications.
Refers to effective income tax rate reconciliation of warrant liability under mark to market.
Refers to effective income tax rate reconciliation for warrant modifications.
Refers to effective income tax rate reconciliation for other.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from basis differences in fixed assets.
It refers to an legal entity.
It refers to an product information.
Subsequently increase carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.
Price of a single share of a number of saleable stocks of a company.
Information by range of option prices pertaining to options granted.
Information by range of option prices pertaining to options granted.
Information by range of option prices pertaining to options granted.
Information by range of option prices pertaining to options granted.
Refers to amount of initial upfront payment as in cash during the period.
Description of stock trading consective days market price per share.
Refers to amount of non current portion of accrued dividend as on balance sheet date.
Refers to net loss on accrued dividend during the period.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Number of new stock issued during the period.
Refers to number of common shares exchange during the period.
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Refers to carrying value of deemed dividend as on date.
Refers to number of common shares registered during the period.
Refers to amount of fair value of warrant modification during the period.
Refers to increase amount in fair value during the period.
Information pertinent to describing and quantifying a commitment or performance under a commitment to a recipient of an entity's shares (such as to shareholders of an acquired entity) to register the recipient's holdings of such shares, by payment arrangement.
Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
It refers to an legal entity.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
It refers to an legal entity.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
It refers to an related party entity.
It refers to an related party entity.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
It refers to an related party entity.
It refers to an related party entity.
Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements.
It refers to an related party entity.
It refers to an related party entity.
It refers to an legal entity.
Refers to number of contract held during the period.
Refers to amount of cash payment made during the period.
It refers to an related party entity.
Exercise price per share or per unit of warrants or rights outstanding.
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
Amount received for stock sold ito investor.
Non current portion carrying value of warrant liability as on balance sheet date.
Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.
Amount of asset related to consideration paid in advance for technlolgy license fees and all other as on balance sheet date.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the after third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Additional number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.
Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.
Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
The cash inflow from the issuance of gross common stock, preferred stock, treasury stock, stock options, and other types of equity.
Information about conversion of stock.
Refers to amount of loss on settlement of note receivable for common stock purchase during the period.
InvestmentNote1Member
InvestmentNote2Member
InvestmentNote3Member
NotesPayableOtherPayables6Member
Warrant5Member
SecuritiesPurchaseAgreements1Member
Warrant1Member
Warrant11Member
Assets, Current
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Treasury Stock, Value
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Interest Expense
Other Nonoperating Expense
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest
Income Tax Expense (Benefit)
AccruedDividendOnSeriesBPreferredStock
DeemedDividendOnSeriesBPreferredUnits
Foreign Currency Transaction Gain (Loss), before Tax
Gain (Loss) on Disposition of Property Plant Equipment
Increase (Decrease) in Prepaid Expense and Other Assets
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Payments to Acquire Property, Plant, and Equipment
Repayments of Long-term Capital Lease Obligations
Repayments of Notes Payable
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Cash and Cash Equivalents, Period Increase (Decrease)
Shares, Outstanding
Property, Plant and Equipment, Policy [Policy Text Block]
Research, Development, and Computer Software, Policy [Policy Text Block]
Income Tax, Policy [Policy Text Block]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Net Income (Loss) Available to Common Stockholders, Diluted
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
DebtInstrumentAccruedInterestUnamortizedDiscount
Interest Payable
Interest Payable, Current
InterestPayableNoncurrent
DebtInstrumentOtherAbstract
Long-term Debt
Long-term Debt, Current Maturities
Long-term Debt, Excluding Current Maturities
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation
Capital Leases, Balance Sheet, Assets by Major Class, Net
Capital Leases, Future Minimum Payments, Net Minimum Payments
Capital Leases, Future Minimum Payments, Interest Included in Payments
Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Operating Leases, Future Minimum Payments Due, Next Twelve Months
Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Operating Leases, Future Minimum Payments Due
Long-term Debt, Fiscal Year Maturity [Abstract]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months
Long-term Debt, Maturities, Repayments of Principal in Year Two